JP2024528569A5 - - Google Patents
Info
- Publication number
- JP2024528569A5 JP2024528569A5 JP2024500204A JP2024500204A JP2024528569A5 JP 2024528569 A5 JP2024528569 A5 JP 2024528569A5 JP 2024500204 A JP2024500204 A JP 2024500204A JP 2024500204 A JP2024500204 A JP 2024500204A JP 2024528569 A5 JP2024528569 A5 JP 2024528569A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- group
- thc
- cannabis plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221006P | 2021-07-13 | 2021-07-13 | |
| US63/221,006 | 2021-07-13 | ||
| US202163276668P | 2021-11-08 | 2021-11-08 | |
| US63/276,668 | 2021-11-08 | ||
| PCT/IL2022/050734 WO2023286047A1 (en) | 2021-07-13 | 2022-07-07 | Cannabidiolic acid esters for treating prader-willi syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528569A JP2024528569A (ja) | 2024-07-30 |
| JP2024528569A5 true JP2024528569A5 (https=) | 2025-07-08 |
Family
ID=84919088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500204A Pending JP2024528569A (ja) | 2021-07-13 | 2022-07-07 | プラダー・ウィリー症候群を治療するためのカンナビジオール酸エステル |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240316073A1 (https=) |
| EP (1) | EP4370106A4 (https=) |
| JP (1) | JP2024528569A (https=) |
| AU (1) | AU2022312764A1 (https=) |
| CA (1) | CA3224271A1 (https=) |
| IL (1) | IL310009A (https=) |
| WO (1) | WO2023286047A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3062814C (en) * | 2017-04-27 | 2023-11-14 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| US12403114B2 (en) * | 2019-03-12 | 2025-09-02 | Epm (Ip), Inc. | Cannabinoid acid ester compositions and uses thereof |
| WO2021137224A1 (en) * | 2020-01-01 | 2021-07-08 | Epm Group, Inc. | Cannabidiolic acid esters for treating muscular dystrophy |
| CN113087599A (zh) * | 2020-01-08 | 2021-07-09 | 成都百裕制药股份有限公司 | 大麻二酚衍生物及其制备方法和在医药上的应用 |
-
2022
- 2022-07-07 JP JP2024500204A patent/JP2024528569A/ja active Pending
- 2022-07-07 WO PCT/IL2022/050734 patent/WO2023286047A1/en not_active Ceased
- 2022-07-07 US US18/574,167 patent/US20240316073A1/en active Pending
- 2022-07-07 CA CA3224271A patent/CA3224271A1/en active Pending
- 2022-07-07 IL IL310009A patent/IL310009A/en unknown
- 2022-07-07 AU AU2022312764A patent/AU2022312764A1/en active Pending
- 2022-07-07 EP EP22841608.7A patent/EP4370106A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102569534B1 (ko) | 식물 공급원으로부터 칸나비노이드의 선택적 추출 방법 | |
| CN1925853B (zh) | 琥珀酸α-生育酚酯及其类似物和盐的稳定注射组合物 | |
| JP5017035B2 (ja) | プロスタグランジンｅ１を含むエマルション組成物 | |
| US20100004216A1 (en) | Medicinal lipolysis of accumulation of fat | |
| EP4182026A1 (en) | Cannabidiol (cbd) based composition and method for treating pain | |
| BR112012015433B1 (pt) | Composição farmacêutica substancialmente anidra para aplicação cutânea | |
| EP3412276B1 (de) | Zusammensetzung zur behandlung des trockenen auges | |
| US20100129431A1 (en) | Idebenone composition for the treatment of neurological disorders | |
| CN116407543B (zh) | Epa-ee纳米脂质组合物、及其制剂、制备方法和应用 | |
| US11202814B2 (en) | Compositions for atopic skin | |
| CA2701789A1 (fr) | Nouvelles compositions a base de taxoides | |
| JP2024528569A5 (https=) | ||
| US20090131496A1 (en) | Pyrazolone derivative emulsion formulations | |
| WO2022043407A1 (fr) | Compositions destinées au traitement des troubles neurologiques | |
| US20150306221A1 (en) | Mixture of Betamethasone and Tranilast with a Transdermal Gel for Scar Treatment | |
| WO2019152560A1 (en) | Compositions and methods for topical treatment of dermal and ocular conditions | |
| EP0834312B1 (de) | Topisches Arzneimittel auf Basis von Diclofenac | |
| DE4021084C1 (en) | Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant | |
| US8637688B2 (en) | Topical dosage form comprising tri-substituted glycerol compounds | |
| US12447192B1 (en) | Stable cannabinoid-comprising nanoemulsions and methods of using the same | |
| CN107708669B (zh) | 用于肠胃外给药的丙泊酚乳液 | |
| US20240366633A1 (en) | Methods for treatment of opioid use disorder with cannabinoids | |
| WO2022101678A2 (en) | Lysophospholipid formulations | |
| WO2025233977A1 (en) | Highly bioavailable omega-3 fish oil nanoemulsion (epa and dha) as a nutraceutical formulation for cardiovascular health management | |
| WO2023019111A1 (en) | Pharmaceutical formulations of cannabidiol |